GST 2.0: Life-saving drugs to diabetes pills, healthcare gets cheaper – Full details
The new GST rates in India have lowered the tax burden on pharmaceutical products, making them more affordable for all socio-economic groups and boosting domestic manufacturing and innovation. IPA highlights that patients with rare diseases, cancer, and genetic disorders will see significant cost savings.